| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 64315-16-8 | 血管緊張素原 | ANGIOTENSINOGEN; H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-Phe-His-LEU-LEU-VAL-TYR-SER-OH; ASP-ARG-VAL-TYR-ILE-HIS-PRO-Phe-His-LEU-LEU-VAL-TYR-SER; ANGIOTENSINOGEN FRAGMENT 1-14 PORCINE; ANGIOTENSINOGEN (1-14), PORCINE; ANGIOTENSINOGEN (1-14) (HORSE); ANGIOTENSINOGEN; PREANGIOTENSINOGEN (1-14) (HORSE); RENIN SUBSTRATE |  | C85H123N21O20 | 詳情 | 供應商 |
| 220673-95-0 | (D-PHE11,HIS12)-SAUVAGINE (11-40) | ANTISAUVAGINE-30; D-Phe-His-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2; (D-PHE11,HIS12)-SAUVAGINE (11-40); (D-PHE11,HIS12)-SAUVAGINE (11-40) TRIFLUOROACETATE SALT; H-D-Phe-His-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THE-ILE-OH; H-D-Phe-His-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2; ANTISAUVAGINE-30; M.W. 3650.29 C161H274N48O46S |  | C161H273N47O47S | 詳情 | 供應商 |
| 170809-51-5 | DPhe-His-LEU-LEU-ARG-GLU-VAL-LEU-GLU-NLE-ALA-ARG-ALA-GLU-GLN-LEU-ALA-GLN-GLU-ALA-HIS-LYS-ASN-ARG-LYS | ASTRESSIN; H-D-Phe-His-LEU-LEU-ARG-GLU-VAL-LEU-GLU-NLE-ALA-ARG-ALA-GLU-GLN-LEU-ALA-GLN-CYCLO(-GAMMA-GLU-ALA-HIS-EPSILON-LYS)-ASN-ARG-LYS-LEU-NLE-GLU-ILE-ILE-NH2; [D-PHE12, NLE21,38, GLU30, LYS33]-CORTICOTROPIN RELEASING FACTOR (12-41) (HUMAN, RAT); [D-PHE12,NLE21,38,GLU30,LYS33]-CORTICOTROPIN RELEASING FACTOR FRAGMENT 12-41; [D-PHE12, NLE21,38, GLU30, LYS33]-CRF (12-41), CYCLIC LACTAM, HUMAN, RAT; [D-PHE12, NLE21,38, GLU30, LYS33]-CRF (12-41) (HUMAN, RAT); (D-PHE12,NLE21,38,GLU30,LYS33)-CRF (12-41)(HUMAN, RAT) (CYCLIZED BETWEEN GAMMA-GLU30 ANDEPSILON-LYS33); (D-PHE12,NLE21,38,GLU30,LYS33)-CRF (12-41) (HUMAN, RAT) TRIFLUOROACETATE SALT; D-Phe-His-LEU-LEU-ARG-GLU-VAL-LEU-GLU-NLE-ALA-ARG-ALA-GLU-GLN-LEU-ALA-GLN-GLU-ALA-HIS-LYS-ASN-ARG-LYS-LEU-NLE-GLU-ILE-ILE-NH2 |  | C161H269N49O42 | 詳情 | 供應商 |
| 50410-01-0 | H-HIS-PRO-Phe-His-LEU-D-LEU-VAL-TYR-OH | H-HIS-PRO-Phe-His-LEU-D-LEU-VAL-TYR-OH; H-HIS-PRO-Phe-His-LEU-D-LEU-VAL-TYR-OH; HIS-PRO-Phe-His-LEU-D-LEU-VAL-TYR; HPFHLLVY; RENIN INHIBITOR PEPTIDE; HISTIDINE-PROLINE-PHENYLALANINE-HISTIDINE-LEUCINE-D-LEUCINE-VALINE- TYROSINE); H-His-Pro-Phe-His-Leu-D-Leu-Val-Tyr-NH2; histidine-proline-phenylalanine-histidine-leucine-valine; [D-Leu6}-Octapeptide |  | C52H72N12O10 | 詳情 | 供應商 |
| 434938-41-7 | K 41498; K 41498; D-Phe-His-LEU-LEU-ARG-LYS-NLE-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2; M.W. 3630.07 C162H276N48O46 |  | C162H276N48O46 | 詳情 | 供應商 | |
| 110200-37-8 | ASP-ARG-VAL-TYR-ILE-HIS-PRO-Phe-His-LEU-LEU-TYR-TYR-SER | ANGIOTENSINOGEN (1-14) (RAT); TETRADECAPEPTIDE RENIN SUBSTRATE (RAT); RENIN SUBSTRATE TETRADECAPEPTIDE, RAT; PREANGIOTENSINOGEN (1-14); PREANGIOTENSINOGEN (1-14) (RAT); H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-Phe-His-LEU-LEU-TYR-TYR-SER-OH; ASP-ARG-VAL-TYR-ILE-HIS-PRO-Phe-His-LEU-LEU-TYR-TYR-SER; ANGIOTENSINOGEN (1-14) (RAT); Angiotensi |  | C89H123N21O21 | 詳情 | 供應商 |